Reducing AIDS Stigma Among Health Professionals in India

Status Completed

Clinical Trial Summary

This Randomized Controlled Trial has been designed to test the efficacy of a behavioral intervention to reduce HIV-related stigma among nursing students and ward attendants in 16 sites in South India and 8 sites in North India.

Clinical Trial Description

Across the globe, HIV stigma inflicts hardship and suffering on people with HIV and has been found to reduce the likelihood of seeking HIV counseling and testing and PMTCT. Stigma also deters infected individuals from disclosing their status, seeking timely medical treatment for HIV-related problems, reduces ART adherence, and leads to delays in clinic appointments and prescription refills, which can lead to virologic failure and the development and transmission of drug resistance. Medical professionals unfortunately constitute a significant source of stigma for PLHIV.

This study will evaluate the efficacy of a promising intervention designed to reduce HIV stigma among Indian health professionals. The intervention builds on results of our previous research, identifying prevalence and drivers of stigma and discrimination in Indian healthcare settings among PLHIV, health care providers and uninfected patients.

Specifically, the study will:

1. Adapt our pilot-tested 3-session stigma reduction intervention for partial tablet-based delivery to increase its long-term sustainability in health care settings. The two tablet-administered sessions of the intervention use interactive touch screen methodology and video vignettes tailored to situations likely to be encountered by Indian nurses and ward attendants. The third session focuses on skills-building in a group format and is co-facilitated by a PLHIV.

2. Evaluate the efficacy of the intervention in 24 hospitals in North and South India on:

1. behavioral manifestations of HIV stigma, including endorsement of coercive policies, behavioral intentions to discriminate, and non/stigmatizing provider-patient interactions.

2. the factors underlying stigma proposed by our conceptual model and targeted in the intervention modules, including fears and misconceptions regarding casual transmission (instrumental stigma), and negative attitudes toward marginalized, vulnerable groups (symbolic stigma). ;

Study Design

Related Conditions & MeSH terms

Stigmatization

Clinical Trial Details

NCT number	NCT02101697
Study type	Interventional
Source	University of California, San Francisco
Contact
Status	Completed
Phase	N/A
Start date	July 2014
Completion date	August 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05755165` - Adolescent Depression: Video Ads on Instagram	N/A
Completed	`NCT03750864` - Innovative Approach to Reduce Lung Cancer Stigma	N/A
Completed	`NCT05124665` - Interrupting HIV and TB Stigma in the Household in Uganda	N/A
Completed	`NCT03695393` - Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs	N/A
Recruiting	`NCT04420442` - Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars	N/A
Completed	`NCT05596305` - Outcomes of Anti Stigma Educational Intervention of Ungraduated Medical Students	N/A
Completed	`NCT04087954` - Evaluation the Impact of Self-Stigma Reduction Program on Psychosocial Outcomes Among People Diagnosed With Schizophrenia	N/A
Not yet recruiting	`NCT06434805` - An Education Initiative to Reduce Stigma Towards Sex Workers and Sexual Minorities Among Nursing Students	N/A
Recruiting	`NCT02280889` - Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
Active, not recruiting	`NCT05907174` - Siyakhana Peer: Evaluating a Peer Recovery Coach Model to Reduce Substance Use Stigma in South African HIV Care	N/A
Recruiting	`NCT06402929` - Honest, Open, Proud - College for Post-Secondary Students With Mental Health Challenges	N/A
Recruiting	`NCT05785169` - Ending the HIV Epidemic With Equity: an Intervention to Reduce the Impact of Racism and Discrimination	N/A
Recruiting	`NCT06316804` - Mobile Mental Health Stigma Reduction Intervention Among Black Adults	N/A
Not yet recruiting	`NCT05415891` - The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta	N/A
Completed	`NCT05980832` - Effect of Peer-Supported Psychosocial Skills Training in Individuals With Chronic Mental Disorder	N/A
Completed	`NCT04644978` - European Study on the Attitude of Psychiatrists Towards Their Patients
Completed	`NCT05271903` - Simulation Training for Labor and Delivery Providers to Address HIV Stigma During Childbirth in Tanzania	N/A
Completed	`NCT05935345` - Addressing Nonsuicidal Self-injury in Schools	N/A
Completed	`NCT05770804` - Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels	N/A
Completed	`NCT03231761` - Impact of Video Presentations on Medical Students' Attitudes Toward Mental Illness	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Reducing AIDS Stigma Among Health Professionals in India — DRISTI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms